Anagrelide for the Treatment of Essential Thrombocythemia: Real‐World Observational Study in a Cohort of Colombian Patients

Advances in Hematology · Published 2026-01-01 · DOI 10.1155/ah/6306409

Authors being retrieved — see the publisher record. https://doi.org/10.1155/ah/6306409

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Outcomes of Diffuse Large B‐Cell Lymphoma in Older Adults Treated in Resource‐Constrained Settings · Advances in Hematology · 2026 · Same journal
SGLT2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series · Advances in Hematology · 2025 · Same journal
Real‐World Safety and Efficacy of Venetoclax in Chronic Lymphocytic Leukemia: A Single‐Center Comparative Analysis With Randomized Clinical Trials · Advances in Hematology · 2025 · Same journal
The Endothelial‐Independent Effect of Desmopressin, In Vitro, on Platelet Function · Advances in Hematology · 2025 · Same journal
Risk‐Stratified and Response‐Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience · Advances in Hematology · 2025 · Same journal
Soluble B‐cell Maturation Antigen in Multiple Myeloma and Correlation With Response to Therapy · Advances in Hematology · 2025 · Same journal
Incidence of Induction Toxicities in Childhood Acute Lymphoblastic Leukaemia in Ghana · Advances in Hematology · 2026 · Same journal
Evaluation of Vaso‐Occlusive Crises in Brazilian Sickle Cell Patients Before and After Crizanlizumab: A Real‐World Study · Advances in Hematology · 2026 · Same journal
Advancements in B‐Cell Non‐Hodgkin’s Lymphoma: From Signaling Pathways to Targeted Therapies · Advances in Hematology · 2024 · Same journal
Investigating the Role of HOTAIR and MALAT1 Long Noncoding RNAs and Their Relations With Bone Marrow Environment in Acute Myeloid Leukemia Subtypes: Biomarkers and Treatment Response · Advances in Hematology · 2025 · Same journal